Basal secretion was collected from the pouch for four 15-min periods. Gastrin (0.4 or 0.8 g/kg per hr) or histamine dihydrochloride (0.04 mg/kg per hr) was then added to the saline in the intravenous infusion The gastrin used was prepared by the method of Gregory and Tracy (7) (Fig. 2) . Against the same stimulation a physiological dose (see DISCUSSION) of secretin (4 U/kg per hr) caused complete inhibition of secretion. The time courses of the two inhibitions were almost identical, except that against this submaximal dose of gastrin, secretin inhibition lasted longer after the infusion was over than did acid inhibition.
When secretion was stimulated with a dose of gastrin known to be near maximal (0.8 g/kg per hr), the same infusate of acid produced a 75 % inhibition, while the the same dose of secretin inhibited secretion 90 70 (Fig. 3) . Again the inhibition caused by secretin was greater than that caused by acid. Histamine-stimulated wretion.
The above experiments were repeated using a dose of 0.04 mg histamine dihydrochloride/kg per hr to stimulate secretion (Fig. 4) . The responses to this dose of histamine and to the higher dose of gastrin were about equal. Neither the duodenal infusion of acid nor the intravenous infusion of secretin produced any inhibition of gastric secretion. In this respect, too, the responses to acid and secretin were identic al. The hormone was discovered by Ivy and Farrell in 1925 (9) when they observed that feeding fat inhibited the motility of a transplanted fundic pouch. Evidence soon followed that the inhibition of gastric secretion by fat was also humoral in nature. Feng et al. (2) showed that if fat were added to a meat meal, the expected secretion from a transplanted fundic pouch failed to materialize.
They offered proof that the inhibitory agent was not an absorbed digestion product of fat and presumed it to be a hormone liberated from the duodenal mucosa. Inhibition of gastric secretion by acid in the duodenum is well documented ( 11 j 15). The evidence also shows that this inhibition is, at least in part, hormonal in nature (1,15).
The conclusion that a hormone existed in the duodenum which inhibited gastric secretion prompted a search for it in duodenal extracts. Kosaka and Lim found that an extract of duodenum made after exposure to olive oil inhibited secretion and named the active principle enterogastrone ( X0). Subsequent attempts to extract enterogastrone were made by many investigators, who found it relatively easy to obtain substances which would inhibit the acid response to a meal. This work has been reviewed recently by Gregory (6). The most recent chapter in the enterogastrone story concerns the effects of other duodenal hormones on gastric secretion. Greenlee et al. (4) found that a crude commercial extract of secretin inhibited pouch secretion stimulated by gastrin. Gillespie and Grossman (3) showed that a duodenal preparation having cholecystokinin-pancreozymin activity also inhibited gastric secretion.
In an earlier study from this laboratory ( 14) synthetic secretin was shown to inhibit gastrin-stimulated secretion, leaving no doubt that secretin per se is an inhibitor. In the experiments reported here a pure form of secretin was administered by continuous intravenous infusion, which more closely mimics physiological release than does a single injection.
In studies conducted on four other dogs with pancreatic fistulas the dose of secretin used here (4 U/kg per hr) was found to produce approximately 90 % of the maximal pancreatic response and is therefore regarded as a "physiological" dose since it is submaximal.
The effects of this dose of secretin on gastric secretion from Heidenhain pouches stimulated by gastrin and histamine were compared to the REFERENCES by our use of a constant infusion of secretin rather than a single shot and exogenous rather than endogenous acid. Grossman (8) has recently suggested two criteria to be used to help decide whether the action of a hormone is physiological.
First, the effect must be produced by a dose given by constant intravenous infusion that is submaximal for the primary response to the hormone. Second, it must be possible to reproduce the effect in kind and magnitude by endogenous hormone. The inhibitory effect of secretin on gastric acid secretion clearly meets these criteria.
With near-maximal stimulation by exogenous gastrin we obtained nearly complete inhibition of gastric secretion using a physiological dose of secretin.
In addition these experiments show that secretin can account for all the inhibition of gastric acid secretion produced by acid in the duodenum. Therefore, we conclude that secretin is probably the only enterogastrone released by acid in the duodenum. Whether there is a separate enterogastrone released by the presence of other substances in the duodenum remains an open question.
